These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2866705)

  • 21. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unstable angina. Rational approach to management.
    Flaherty JT
    Am J Med; 1984 Jun; 76(6A):52-7. PubMed ID: 6146257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines.
    Aronow WS
    Expert Opin Pharmacother; 2016; 17(2):205-15. PubMed ID: 26373919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists for Prinzmetal's variant angina, unstable angina and silent myocardial ischemia: therapeutic tool and probe for identification of pathophysiologic mechanisms.
    Stone PH
    Am J Cardiol; 1987 Jan; 59(3):101B-115B. PubMed ID: 3544788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of beta-adrenergic blockers in the treatment of angina and hypertension.
    Caris TN
    Angiology; 1986 Mar; 37(3 Pt 2):215-7. PubMed ID: 2871779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists. Clinical use in the treatment of systemic hypertension.
    Spivack C; Ocken S; Frishman WH
    Drugs; 1983 Feb; 25(2):154-77. PubMed ID: 6339198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
    Kawanishi DT; Reid CL; Gonzales A; O'Rourke RA; Rahimtoola SH
    Circulation; 1989 Dec; 80(6 Suppl):IV162-70. PubMed ID: 2574640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia?
    Slogoff S; Keats AS
    Anesthesiology; 1988 May; 68(5):676-80. PubMed ID: 2897173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geriatric hypertension: antihypertensive therapy in coronary artery disease.
    Gonzalez DG; Ram CV
    Geriatrics; 1987 Dec; 42(12):45-7, 50. PubMed ID: 2890556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and pharmacodynamic properties of beta-blocking drugs influencing choice in treatment of systemic hypertension.
    Harrison DC
    Am J Cardiol; 1987 Sep; 60(9):13E-16E. PubMed ID: 2889349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-entry blocking agents in the treatment of systemic hypertension.
    Robinson BF
    Am J Cardiol; 1985 Jan; 55(3):102B-106B. PubMed ID: 2857516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers.
    Massie BM
    Am J Cardiol; 1985 Dec; 56(16):97H-100H. PubMed ID: 2866709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of myocardial ischemia.
    Gorlin R
    Major Probl Intern Med; 1976; 11():232-62. PubMed ID: 10490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of calcium antagonists in hypertension: update 1986.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S29-35. PubMed ID: 2455135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.